Abstract
Cortactin and HS1 are actin‐binding molecules known to be overexpressed in leukemic B‐cells from adult patients with chronic lymphoid leukemia. Both proteins are required for proper actin remodeling in virtually all cell types. While cortactin overexpression is associated to invasiveness of various solid tumor cells, HS1 is correlated with poor prognosis of chronic leukemia in adult patients. However, the role of cortactin and HS1 in childhood acute lymphoblastic leukemias (ALL) has never been studied. Here, we analyzed mRNA levels of both cortactin and HS1 in model cell lines for ALL and primary bone marrow (BM) cells from B‐ALL patients, and found substantial increases for both cortactin and HS1 in leukemic cells compared to controls. Furthermore, protein levels of cortactin were highest within primary primitive Lin‐CD34+ stem and progenitor cell compartments, while lineage committed CD34‐CD19+ and non‐B cells displayed low expression levels. By contrast, HS1 expression was high but did not change during differentiation. Unraveling the importance of differential expression of cortactin and HS1 in leukemia initiating cells for the population dynamics and development of childhood acute leukemias may open novel treatment strategies to prevent progression of the disease with infiltrations into other organs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.